Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study-Reference-Cited by-同舟云学术

Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study

Published:2019-04-30 Issue:6 Volume:8 Page:3296-3304
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Foulon Stéphanie¹²³^ORCID,Cony‐Makhoul Pascale⁴⁵,Guerci‐Bresler Agnès⁵⁶,Delord Marc⁵⁷^ORCID,Solary Eric⁸⁹,Monnereau Alain¹⁰¹¹¹²,Bonastre Julia¹²,Tubert‐Bitter Pascale³

Affiliation:

1. Biostatistics Unit Gustave Roussy Villejuif France

2. CESP Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris‐Sud Univ Villejuif France

3. B2PHI Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases Inserm U1181, UVSQ, Paris Saclay Univ Villejuif France

4. Service d'Hématologie CH Annecy Genevois Pringy France

5. FiLMC Group, Institut Bergonié Bordeaux France

6. Service d'Hématologie CHRU Brabois Vandoeuvre France

7. Institut Universitaire d'Hématologie Université Paris‐Diderot Paris7 Paris France

8. Department of Hematology Gustave Roussy Villejuif France

9. INSERM U1170 Villejuif France

10. University of Bordeaux, Inserm, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219 Bordeaux France

11. Registre des Hémopathies Malignes de la Gironde, Institut Bergonié Bordeaux France

12. French Network of Population‐based Cancer Registries (FRANCIM) Toulouse France

Funder

French National Agency for Research

French Institute for Public Health Research

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2200

Reference33 articles.

1. Cancer incidence in France over the 1980–2012 period: Hematological malignancies

2. Epidemiology of chronic myeloid leukaemia: an update

3. Chronic myeloid leukaemia

4. Population-based assessment of chronic myeloid leukemia in Sweden: striking increase in survival and prevalence

5. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leucémie myéloïde chronique : vingt ans d’analyses ciblées sur l’imatinib;Bulletin de l'Académie Nationale de Médecine;2023-06

2. Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories—A French population‐based study using the French national health data system;American Journal of Hematology;2022-06-07

3. Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study;Supportive Care in Cancer;2022-03-18

4. Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France;Frontiers in Oncology;2021-09-30

5. Health state utility and quality of life measures in patients with chronic myeloid leukemia in France;Quality of Life Research;2021-03-02